Literature DB >> 36072765

A rare B-cell type chronic active Epstein-Barr virus infection patient mimicking lymphoma on 18F-FDG PET/CT and literature review.

Hao Jiao1, Yongbai Zhang1, Zhao Chen1, Xueqi Chen1, Yongkang Qiu1, Wenpeng Huang1, Lin Nong2, Lei Kang1.   

Abstract

A 13-year-old girl suffered from worsen snoring and persistent bilateral nasal congestion for one year. Paranasal sinus computed tomography (CT) and magnetic resonance imaging (MRI) found nasopharyngeal passages and sinus were occupied with soft tissues and bilateral neck enlarged lymph nodes 6 months ago. Tumor markers were normal. The titers of anti-Epstein-Barr virus (EBV) IgM, anti-EBV IgG, early antigen (EA) IgG, and Epstein-Barr nuclear antigen (EBNA) IgG increased. 2-Deoxy-2-[fluorine-18]-fluoro-D-glucose (18F-FDG) positron emission tomography combined with CT (PET/CT) revealed thickened soft tissues in nasopharynx and oropharynx, enlarged multiple lymph nodes in the neck, bilateral armpits, abdominal cavity and retroperitoneum, and pelvic cavity, diffuse thickening of the gastric wall of the antrum with hypermetabolism. According to the age, situation, regions, and abnormal FDG uptake, an initial diagnosis of EBV-related lymphoma was made. However, the pathological results of the nasopharyngeal mass and the abdominal lymph node confirmed the final diagnosis of a B-cell type chronic active Epstein-Barr virus disease (CAEBV), a rare type of EBV associated lymphoproliferative disorder (LPD). After receiving adoptive immune cells therapy, the EBV load decreased. At present, the patient is being followed up. AJNMMI
Copyright © 2022.

Entities:  

Keywords:  18F FDG; B cell; Epstein-Barr virus (EBV) associated lymphoproliferative disorders; PET/CT; chronic active EBV disease

Year:  2022        PMID: 36072765      PMCID: PMC9441925     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  41 in total

1.  Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies.

Authors:  J F Jones; C G Ray; L L Minnich; M J Hicks; R Kibler; D O Lucas
Journal:  Ann Intern Med       Date:  1985-01       Impact factor: 25.391

2.  Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection.

Authors:  Hiroshi Kimura; Yo Hoshino; Shinya Hara; Naomi Sugaya; Jun-Ichi Kawada; Yukiko Shibata; Seiji Kojima; Tetsuro Nagasaka; Kiyotaka Kuzushima; Tsuneo Morishima
Journal:  J Infect Dis       Date:  2005-01-06       Impact factor: 5.226

3.  Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.

Authors:  Jeffrey I Cohen; Elaine S Jaffe; Janet K Dale; Stefania Pittaluga; Helen E Heslop; Cliona M Rooney; Stephen Gottschalk; Catherine M Bollard; V Koneti Rao; Adriana Marques; Peter D Burbelo; Siu-Ping Turk; Rachael Fulton; Alan S Wayne; Richard F Little; Mitchell S Cairo; Nader K El-Mallawany; Daniel Fowler; Claude Sportes; Michael R Bishop; Wyndham Wilson; Stephen E Straus
Journal:  Blood       Date:  2011-03-31       Impact factor: 22.113

4.  Prognostic factors for chronic active Epstein-Barr virus infection.

Authors:  Hiroshi Kimura; Tsuneo Morishima; Hirokazu Kanegane; Shouichi Ohga; Yo Hoshino; Akihiko Maeda; Shosuke Imai; Motohiko Okano; Tomohiro Morio; Shumpei Yokota; Shigeru Tsuchiya; Akihiro Yachie; Shinsaku Imashuku; Keisei Kawa; Hiroshi Wakiguchi
Journal:  J Infect Dis       Date:  2003-01-28       Impact factor: 5.226

5.  EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.

Authors:  Hiroshi Kimura; Yoshinori Ito; Shinji Kawabe; Kensei Gotoh; Yoshiyuki Takahashi; Seiji Kojima; Tomoki Naoe; Shinichi Esaki; Atsushi Kikuta; Akihisa Sawada; Keisei Kawa; Koichi Ohshima; Shigeo Nakamura
Journal:  Blood       Date:  2011-11-16       Impact factor: 22.113

6.  Active myocarditis in a patient with chronic active Epstein-Barr virus infection.

Authors:  Hiroyuki Takano; Keiichi Nakagawa; Naoki Ishio; Michiko Daimon; Masao Daimon; Yoshio Kobayashi; Kenzo Hiroshima; Issei Komuro
Journal:  Int J Cardiol       Date:  2007-10-25       Impact factor: 4.164

7.  Chronic Active Epstein-Barr Virus-Associated Enteritis: CT Findings and Clinical Manifestation.

Authors:  Bo Zhang; Xia Wang; Xiaoyan Tian; Yongping Cai; Xingwang Wu
Journal:  Biomed Res Int       Date:  2020-06-22       Impact factor: 3.411

8.  Chronic meningitis and central nervous system vasculopathy related to Epstein Barr virus.

Authors:  Anil Kumar B Patil; Zeyaur Rahman Azad; Vivek Mathew; Mathew Alexander
Journal:  Ann Indian Acad Neurol       Date:  2012-10       Impact factor: 1.383

9.  EBV-Positive T/NK-Cell Lymphoproliferative Disease of Childhood.

Authors:  Mineui Hong; Young Hyeh Ko; Keon Hee Yoo; Hong Hoe Koo; Seok Jin Kim; Won Seog Kim; Heejung Park
Journal:  Korean J Pathol       Date:  2013-04-24

10.  A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.

Authors:  Keisuke Kawamoto; Hiroaki Miyoshi; Takaharu Suzuki; Yasuji Kozai; Koji Kato; Masaharu Miyahara; Toshiaki Yujiri; Ilseung Choi; Katsumichi Fujimaki; Tsuyoshi Muta; Masaaki Kume; Sayaka Moriguchi; Shinobu Tamura; Takeharu Kato; Hiroyuki Tagawa; Junya Makiyama; Yuji Kanisawa; Yuya Sasaki; Daisuke Kurita; Kyohei Yamada; Joji Shimono; Hirohito Sone; Jun Takizawa; Masao Seto; Hiroshi Kimura; Koichi Ohshima
Journal:  Haematologica       Date:  2017-12-14       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.